List of works - Miriam Saiz Rodríguez

Author's Response to: 'Letter to the Editor in Response to: "Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally"'

scientific article published on 24 December 2019

CYP2C19 Ultrarapid Phenotype as a Risk Predictor of Subsequent Events During Clopidogrel Treatment in Patients Undergoing a Percutaneous Neurointervention.

scientific article published on 16 January 2019

Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants

scientific article published on 13 June 2018

Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects

scientific article published on 15 May 2020

Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally

scientific article published on 03 September 2019

Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.

scientific article published on 14 November 2017

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates

scientific article published on 22 April 2020

Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers

scientific article published on 01 October 2019

Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects

scientific article published on 25 September 2018

Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis.

scientific article published on 30 March 2017

Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling

scientific article published on 17 September 2020

Histone modifications associated with biological drug response in moderate-to-severe psoriasis

scientific article published on 01 December 2018

How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?

article

Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19)

scientific article published on 16 September 2020

Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers

scientific article published on 18 October 2019

Influence of CYP2C19 phenotype on the effect of clopidogrel in patients undergoing percutaneous neurointervention procedure.

scientific article published on 14 March 2018

Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

scientific article published on 11 January 2018

Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention

scientific article published on 23 May 2019

Influence of tpmt polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers

scientific article published on 15 November 2018

Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics

scientific article published on 15 June 2020

Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial

scientific article published on 09 July 2020

Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis

scientific article published on 18 September 2017

Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safety

scientific article published on 24 October 2017

Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.

scientific article

Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis.

scientific article published on 4 May 2017

Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects

scientific article published on 30 October 2018

Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics

scientific article published on 21 February 2019

Prediction models for voriconazole pharmacokinetics based on pharmacogenetics: AN exploratory study in a Spanish population

scientific article published on 04 July 2019

Risk of COVID-19 in oncohematological patients